Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese Patients
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
CONTEXT: Cytochrome P450 oxidoreductase (POR) deficiency is a rare autosomal recessive disorder characterized by skeletal dysplasia, adrenal dysfunction, disorders of sex development (DSD), and maternal virilization during pregnancy. Although multiple studies have been performed for this condition, several matters remain to be clarified, including the presence of manifesting heterozygosity and the underlying factors for clinical variability. OBJECTIVE: The objective of the study was to examine such unresolved matters by detailed molecular studies and genotype-phenotype correlations. PATIENTS: Thirty-five Japanese patients with POR deficiency participated in the study. RESULTS: Mutation analysis revealed homozygosity for R457H in cases 1-14 (group A), compound heterozygosity for R457H and one apparently null mutation in cases 15-28 (group B), and other combinations of mutations in cases 29-35 (group C). In particular, FISH and RT-PCR sequencing analyses revealed an intragenic microdeletion in one apparent R457H homozygote, transcription failure of apparently normal alleles in three R457H heterozygotes, and nonsense mediated mRNA decay in two frameshift mutation-positive cases examined. Genotype-phenotype correlations indicated that skeletal features were definitely more severe, and adrenal dysfunction, 46,XY DSD, and pubertal failure were somewhat more severe in group B than group A, whereas 46,XX DSD and maternal virilization during pregnancy were similar between two groups. Notable findings also included the contrast between infrequent occurrence of 46,XY DSD and invariable occurrence of 46,XX DSD and pubertal growth pattern in group A mimicking that of aromatase deficiency. CONCLUSIONS: The results argue against the heterozygote manifestation and suggest that the residual POR activity reflected by the R457H dosage constitutes the underlying factor for clinical variability in some features but not other features, probably due to the simplicity and complexity of POR-dependent metabolic pathways relevant to each phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in POR can lead to Cytochrome P450 oxidoreductase deficiency (PORD; OMIM 613,571 and 201750), a rare form of congenital adrenal hyperplasia, disrupting the steroid production in the adrenal and gonads [2,9].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [9]
In the citing paper
“Using MLPA, we were able to identify a partial deletion (exons U1–1), also previously described elsewhere (14), and for the first time a partial duplication (exons 2–5) of the POR gene on alleles with no mutation detected by direct sequencing.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
In the citing paper
“PORD manifests with a wide range of clinical signs and symptoms, and our study shows a broader phenotypic expression in Caucasian patients than previously observed in a large Japanese cohort (3, 7, 14, 15).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
In the citing paper
“The Japanese data suggest that p.R457H might be associated with virilization in 46,XX patients but most likely results in normal male genital development (14).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
In the citing paper
“However, apart from a large Japanese series of patients mainly carrying the p.R457H mutation in homozygous or compound heterozygous state (14), no report on a clinically well-characterized PORD patient cohort has addressed this important clinical issue systematically.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151 · cited 1×
“pattern of cases 2 and 3 without scoliosis is considered to represent a mild form of that of male patients with aromatase deficiency (28, 29).”
BackgroundMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 3×
“Because the microdeletion was found in case 21 with apparent R457H homozygosity, such a microdeletion might be hidden in the previously reported patients with apparent homozygosity (1, 5).”
BackgroundSelf-citationPosition effect in human genetic disease
Kleinjan, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.10.1611 · Cited by 370
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347 · cited 1×
“the fetal testis, backdoor pathway, and placenta (3, 4, 9, 25, 26) (Fig.”
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345 · cited 1×
“In this regard, A287P is common in Caucasian patients (4, 5), and clinical studies in 10 A287Ppositive patients including three homozygotes (five with 46,XY and five with 46,XX) have suggested phenotypic similarities and differences between R457H-positive patients and A287P-positive patients: 1) skeletal phenotype is…”
BackgroundHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Carter, M. S., Doskow, J., Morris, P., Li, S., Nhim, R. P., Sandstedt, S., & Wilkinson, M. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28995 · Cited by 329
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges
Kuzmiak, H. A., & Maquat, L. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.005 · Cited by 253
Research works printed but not linked: 2
- Yokoya, 1983, Penile and clitoral sizes in premature newborns, full term neonates, infants, and children, Horumon to Rinsho, 31, 1215
- Hasegawa, 2003, Normal range of GnRH and hCG stimulation tests. In: Let’s enjoy pediatric endocrinology
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
A Genetic-Pathophysiological Framework for Craniosynostosis
Twigg, S. R. F., & Wilkie, A. O. M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.006 · Cited by 276
Flück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Metadata
- Authors
- Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., Kowase, T., Motomura, K., Haruna, H., Nakamura, M., Ohishi, A., Adachi, M., Tajima, T., Hasegawa, Y., Hasegawa, T., Horikawa, R., Fujieda, K., & Ogata, T.
- Affiliations
- National Center For Child Health and Development (JP)
- Tokyo Metropolitan Kiyose Children's Hospital (JP)
- Keio University Hospital (JP)
- Dokkyo Medical University Saitama Medical Center (JP)
- Tottori University Hospital (JP)
- Shizuoka Children's Hospital (JP)
- Yamagata University Hospital (JP)
- University of Miyazaki Hospital (JP)
- Osaka Women's and Children's Hospital (JP)
- Gunma University Hospital (JP)
- Nagasaki University Hospital (JP)
- Juntendo University Hospital (JP)
- Kagoshima University Hospital (JP)
- Hamamatsu University Hospital (JP)
- Kanagawa Children's Medical Center (JP)
- Hokkaido University (JP)
- Asahikawa Medical College Hospital (JP)
- Corresponding author
- Fukami, Maki
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-05-01
- Volume
- 94
- Issue
- 5
- Pages
- 1723-1731
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1990664334
- Cited by
- 117
- References
- 37
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 11 · 2021: 7 · 2020: 9 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 5 · 2014: 4 · 2013: 7 · 2012: 7
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- POR, compound heterozygosity, genotype-phenotype correlation, autosomal recessive disorder, skeletal dysplasia, adrenal insufficiency, disorders of sex development, 46,XX disorders of sex development, 46,XY disorders of sex development, pubertal failure, nonsense-mediated mRNA decay, Japanese patients
- MeSH terms
- Adolescent, Adrenal Cortex Hormones, Alleles, Bone Diseases, Child, Child, Preschool, Cytochrome P-450 Enzyme System, Exons, Female, Genotype, Heterozygote, Homozygote, Humans, Infant, Japan, Male, Mutation, Oxidoreductases, Phenotype, Sexual Maturation, Genetic Variation, In Situ Hybridization, Fluorescence, Gene Dosage, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese Patients. https://app.cochat.ai/papers/10.1210/jc.2008-2816
- The paper
- Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., Kowase, T., Motomura, K., Haruna, H., Nakamura, M., Ohishi, A., Adachi, M., Tajima, T., Hasegawa, Y., Hasegawa, T., . . . Ogata, T. (2009). Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese Patients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-2816
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.